Jorge Maspero

Jul 1, 2024 | sciencedirect.com | Jorge Maspero |Megan Hardin |Remy S. Petersen |Danny Cohn

Previous randomized controlled trials have established the efficacy of dupilumab among patients with chronic obstructive pulmonary disease (COPD) treated with triple therapy over 52 weeks of follow-up. This population-based cohort study aimed to explore the long-term safety and effectiveness of dupilumab in patients with COPD. The study included US patients with COPD who were seen between April 2017 and August 2024.

Jun 29, 2023 | resmedjournal.com | Jorge Maspero |Fundacion CIDEA |Kenneth R Chapman

Cookie Preference CenterWe use cookies which are necessary to make our site work. We may also use additional cookies to analyse, improve and personalise our content and your digital experience. For more information, see our Cookie Policy and the list of Google Ad-Tech Vendors. You may choose not to allow some types of cookies. However, blocking some types may impact your experience of our site and the services we are able to offer.

Feb 3, 2023 | jacionline.org | Leonard B. Bacharier |Jorge Maspero |Fundacion CIDEA

Effect Of Tezepelumab On Rescue Medication Use And Night-Time Awakenings In Patients With Severe, Uncontrolled Asthma: Results From The NAVIGATOR Study